NCT03380468 2023-07-20
ECTOP-1004
Fudan University
Phase 2/3 Unknown
Clinical Trials
4 trialsNCT04396457 2023-03-23
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
National Hospital Organization Nagoya Medical Center
Phase 2 Unknown
NCT03706703 2018-10-17
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT03201146 2017-11-17
Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC
West China Hospital
Phase 1/2 Unknown